Tumour necrosis factor as predictor for pulmonary dysfunction after cardiac surgery

Lancet

Volumn 352, Issue 9136, 1998, Pages 1281-1282

  Gilliland, Helen E ^a   Armstrong, Marilyn A ^a   McMurray, Terence J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; BRONCHUS SECRETION; CLINICAL ARTICLE; DISEASE SEVERITY; ENZYME IMMUNOASSAY; HEART SURGERY; HUMAN; LUNG DISEASE; PRIORITY JOURNAL;

EID: 0032541865     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)70488-8     Document Type: Article

References (4)

1. 1 Uter PM, Suter S, Girardin E, et al. High bronchoalveolar levels of tumour necrosis factor and its inhibitors, interleukin-1, interferon, and elastase in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 1992; 145: 1016-22.
2. 2 Donnelly SC, Stricter RM, Griardin E, et al. Interleukin-8 and the development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993; 341: 643-47.
3. 3 Westendorp RGJ, Langermans JAM, Huizinga TWJ, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349: 170-73.
4. 4 Zipp F, Weber F, Huber S, et al. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumour necrosis factor-alpha by HLA DR2 + T cells. Ann Neurol 1995; 38: 723-30.